Steven G E Marsh Selected Research

HLA-DRB1 Chains (HLA DRB1)

11/2014	Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.
2/2010	Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven G E Marsh Research Topics

Disease

11	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 10/2007
8	Leukemia 01/2023 - 09/2007
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2009
6	Melanoma (Melanoma, Malignant) 01/2014 - 01/2005
3	Neoplasms (Cancer) 10/2022 - 10/2009
2	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 02/2010
1	Bronchiolitis Obliterans Syndrome 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022
1	Juvenile Myelomonocytic Leukemia 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Warts (Wart) 01/2016
1	Hodgkin Disease (Hodgkin's Disease) 09/2015
1	Hypersensitivity (Allergy) 11/2014
1	Bile Duct Diseases (Bile Duct Disease) 11/2014
1	HIV Infections (HIV Infection) 01/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2011
1	Infections 02/2010
1	Systemic Scleroderma (Systemic Sclerosis) 02/2010
1	Crohn Disease (Crohn's Disease) 09/2007

Drug/Important Bio-Agent (IBA)

10	KIR ReceptorsIBA 01/2019 - 01/2005
6	Isoantigens (Alloantigen)IBA 01/2014 - 01/2005
4	Peptides (Polypeptides)IBA 01/2023 - 02/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 10/2022
3	LigandsIBA 01/2023 - 05/2014
3	HLA-A Antigens (HLA-A)IBA 01/2019 - 11/2013
3	HLA-C Antigens (HLA-C)IBA 01/2016 - 02/2014
3	HLA-B Antigens (HLA-B)IBA 01/2016 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2010
2	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 01/2019
2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2015 - 02/2010
2	HLA-DRB1 Chains (HLA DRB1)IBA 11/2014 - 02/2010
2	Human Platelet AntigensIBA 01/2010 - 12/2006
1	Calcineurin InhibitorsIBA 01/2024
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2024
1	phytobacteriomycin (PBM)IBA 01/2023
1	HLA-DRB1*03:01 antigenIBA 01/2022
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2021
1	EpitopesIBA 01/2021
1	Minor Histocompatibility AntigensIBA 01/2021
1	Untranslated Regions (Untranslated Region)IBA 01/2019
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2016
1	abacavir (Ziagen)FDA Link 11/2014
1	Natural Killer Cell ReceptorsIBA 10/2010
1	Amino Acids FDA Link 02/2010
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2010
1	NucleotidesIBA 09/2007

Therapy/Procedure

10	Transplantation 01/2023 - 10/2009
7	Cell Transplantation 01/2023 - 01/2009
3	Donor Selection 01/2019 - 10/2010
3	Hematopoietic Stem Cell Transplantation 12/2015 - 09/2007
2	Stem Cell Transplantation 01/2023 - 10/2007
2	Therapeutics 01/2019 - 10/2009